Making a difference
17 November 2014
Anna is making a difference every day to the lives of her patients. With your support, you can make a difference too.
When Melanoma Institute Australia (MIA) patients at the Poche Centre are first diagnosed with advanced melanoma Anna Hoadley is there.
She is our Clinical Nurse Consultant, and serves as a link between patients and their doctor. Anna is someone they can call with questions and to help co-ordinate their care during what is often the most emotionally tumultuous and stressful time of their lives.
When not in the clinic Anna is on the phone to patients talking about treatment options, dealing with side-effects, co-ordinating tests and scans, speaking to family members, organising referrals, triaging new patient referrals, and much more!
“Having someone to co-ordinate care and understand medically what is going on, to understand their treatments and help improve their quality of life, is so important to our patients,” says Anna.
“Without a Clinical Nurse Consultant, there would be a lot more emotional and physical struggle for our patients.”
One of the hundreds of patients that Anna looks after each year is Trish Nugent. Trish has stage 4 melanoma and has benefitted greatly from Anna’s care.
“Knowing that somebody is helping in such a significant way, to keep me around so that I can be with my family for longer, makes me so very grateful,” Trish says.
“Anna is my inspiration and a joy to see every three weeks, even in the low times. She keeps me fighting.”
With more funding we can expand this program to fund Clinical Nurse Consultants at our other affiliate locations and ensure every patient receives this same exceptional level of care
Your donation today will make a tangible difference to the lives of people, like Trish, and make their struggle that much easier by providing a helping hand in their time of need.
The World Health Organisation (WHO) is releasing the 4th edition of Classification of Skin Tumours.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.